Intracellular genomic transplant and methods of therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10166255
APP PUB NO 20170130200A1
SERIAL NO

15224151

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MINNESOTA MINING & MFG. CO./REGENTS OF THE UNIVERSITY OF MINNESOTA; INTIMA BIOSCIENCE, INC.; THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Choudhry, Modassir New York, US 30 243
McIvor, R Scott St. Louis Park, US 36 295
Moriarity, Branden Shoreview, US 34 252
Palmer, Douglas C North Bethesda, US 17 125
Restifo, Nicholas P Chevy Chase, US 46 295
Rosenberg, Steven A Potomac, US 191 3741
Webber, Beau Coon Rapids, US 34 252

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 1, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 1, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00